Oaktree Acquisition Corp. III Life Sciences
OACC
$10.60
$0.020.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.33M | 1.39M | 1.28M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 152.00K | 175.80K | 201.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 1.48M | 1.56M | 1.48M | -- | |
|
|
|||||
| Total Current Assets | 1.48M | 1.56M | 1.48M | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 199.77M | 197.61M | 195.76M | 639.00K | |
| Total Assets | 201.25M | 199.18M | 197.24M | 639.00K | |
|
|
|||||
| Total Accounts Payable | 414.10K | 381.60K | 395.70K | -- | |
| Total Accrued Expenses | -- | -- | -- | 6.90K | |
| Short-term Debt | 11.80K | 11.80K | 11.80K | 109.40K | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 800.90K | 725.90K | 651.00K | 545.70K | |
| Total Other Current Liabilities | 800.90K | 725.90K | 651.00K | 545.70K | |
| Total Current Liabilities | 1.23M | 1.12M | 1.06M | 662.10K | |
|
|
|||||
| Total Current Liabilities | 1.23M | 1.12M | 1.06M | 662.10K | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | 11.80K | 11.80K | 11.80K | 109.40K | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 206.79M | 204.60M | 202.70M | -- | |
| Total Liabilities | 208.01M | 205.71M | 203.76M | 662.10K | |
|
|
|||||
| Common Stock & APIC | 500.00 | 500.00 | 500.00 | 25.00K | |
| Retained Earnings | -6.77M | -6.54M | -6.52M | -48.10K | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -6.76M | -6.54M | -6.52M | -23.10K | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -6.76M | -6.54M | -6.52M | -23.10K | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -6.76M | -6.54M | -6.52M | -23.10K | |
|
|
|||||